Chinese Expert Consensus on Iodine125 Seed Implantation for Recurrent Cervical Cancer in 2021

The treatment modality for recurrent cervical cancer (rCC) is limited, and the prognosis of these patients is poor. Seed implantation could be an important component of rCC management in the context of dose boost or salvage therapy after surgery or radiotherapy, which is characterized by a minimally...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ping Jiang, Lijuan Zou, Lichun Wei, Guanghui Cheng, Baosheng Sun, Fuquan Zhang, Ruoyu Wang, Tiejun Wang, Ang Qu, Xiangkun Yuan, Bin Qiu, Shuhua Wei, Zi Liu, Yunyan Zhang, Junjie Wang
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	radiotherapy recurrent cervical cancer brachytherapy expert consensus three-dimensional printing template Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/411cce5dd29a43a89f1ea25b8f5e50d6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:411cce5dd29a43a89f1ea25b8f5e50d6
record_format	dspace
spelling	oai:doaj.org-article:411cce5dd29a43a89f1ea25b8f5e50d62021-11-09T05:15:23ZChinese Expert Consensus on Iodine125 Seed Implantation for Recurrent Cervical Cancer in 20212234-943X10.3389/fonc.2021.700710https://doaj.org/article/411cce5dd29a43a89f1ea25b8f5e50d62021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.700710/fullhttps://doaj.org/toc/2234-943XThe treatment modality for recurrent cervical cancer (rCC) is limited, and the prognosis of these patients is poor. Seed implantation could be an important component of rCC management in the context of dose boost or salvage therapy after surgery or radiotherapy, which is characterized by a minimally invasive, high local dose, and rapidly does fall, sparing normal tissue. For patients with good performance status and lateral pelvic wall recurrence with an available puncture path, seed implantation was recommended, as well as for selected central pelvic recurrence and extra-pelvic recurrence. The combination of brachytherapy treatment planning system and CT guidance was needed, and three-dimensional printing templates could greatly improve the accuracy, efficiency, and quality of seed implantation to achieve a potential ablative effect and provide an efficient treatment for rCC. However, the recommendations of seed implantation were mainly based on retrospective articles and lack high-quality evidence, and multicenter prospective randomized studies are needed. In this consensus on iodine125 seed implantation for rCC, indication selection, technical process and requirements, dosimetry criteria, radiation protection, combined systemic therapy, and outcomes of seed implantation for rCC are discussed.Ping JiangLijuan ZouLichun WeiGuanghui ChengBaosheng SunFuquan ZhangRuoyu WangTiejun WangAng QuXiangkun YuanBin QiuShuhua WeiZi LiuYunyan ZhangJunjie WangFrontiers Media S.A.articleradiotherapyrecurrent cervical cancerbrachytherapyexpert consensusthree-dimensional printing templateNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	radiotherapy recurrent cervical cancer brachytherapy expert consensus three-dimensional printing template Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	radiotherapy recurrent cervical cancer brachytherapy expert consensus three-dimensional printing template Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Ping Jiang Lijuan Zou Lichun Wei Guanghui Cheng Baosheng Sun Fuquan Zhang Ruoyu Wang Tiejun Wang Ang Qu Xiangkun Yuan Bin Qiu Shuhua Wei Zi Liu Yunyan Zhang Junjie Wang Chinese Expert Consensus on Iodine125 Seed Implantation for Recurrent Cervical Cancer in 2021
description	The treatment modality for recurrent cervical cancer (rCC) is limited, and the prognosis of these patients is poor. Seed implantation could be an important component of rCC management in the context of dose boost or salvage therapy after surgery or radiotherapy, which is characterized by a minimally invasive, high local dose, and rapidly does fall, sparing normal tissue. For patients with good performance status and lateral pelvic wall recurrence with an available puncture path, seed implantation was recommended, as well as for selected central pelvic recurrence and extra-pelvic recurrence. The combination of brachytherapy treatment planning system and CT guidance was needed, and three-dimensional printing templates could greatly improve the accuracy, efficiency, and quality of seed implantation to achieve a potential ablative effect and provide an efficient treatment for rCC. However, the recommendations of seed implantation were mainly based on retrospective articles and lack high-quality evidence, and multicenter prospective randomized studies are needed. In this consensus on iodine125 seed implantation for rCC, indication selection, technical process and requirements, dosimetry criteria, radiation protection, combined systemic therapy, and outcomes of seed implantation for rCC are discussed.
format	article
author	Ping Jiang Lijuan Zou Lichun Wei Guanghui Cheng Baosheng Sun Fuquan Zhang Ruoyu Wang Tiejun Wang Ang Qu Xiangkun Yuan Bin Qiu Shuhua Wei Zi Liu Yunyan Zhang Junjie Wang
author_facet	Ping Jiang Lijuan Zou Lichun Wei Guanghui Cheng Baosheng Sun Fuquan Zhang Ruoyu Wang Tiejun Wang Ang Qu Xiangkun Yuan Bin Qiu Shuhua Wei Zi Liu Yunyan Zhang Junjie Wang
author_sort	Ping Jiang
title	Chinese Expert Consensus on Iodine125 Seed Implantation for Recurrent Cervical Cancer in 2021
title_short	Chinese Expert Consensus on Iodine125 Seed Implantation for Recurrent Cervical Cancer in 2021
title_full	Chinese Expert Consensus on Iodine125 Seed Implantation for Recurrent Cervical Cancer in 2021
title_fullStr	Chinese Expert Consensus on Iodine125 Seed Implantation for Recurrent Cervical Cancer in 2021
title_full_unstemmed	Chinese Expert Consensus on Iodine125 Seed Implantation for Recurrent Cervical Cancer in 2021
title_sort	chinese expert consensus on iodine125 seed implantation for recurrent cervical cancer in 2021
publisher	Frontiers Media S.A.
publishDate	2021
url	https://doaj.org/article/411cce5dd29a43a89f1ea25b8f5e50d6
work_keys_str_mv	AT pingjiang chineseexpertconsensusoniodine125seedimplantationforrecurrentcervicalcancerin2021 AT lijuanzou chineseexpertconsensusoniodine125seedimplantationforrecurrentcervicalcancerin2021 AT lichunwei chineseexpertconsensusoniodine125seedimplantationforrecurrentcervicalcancerin2021 AT guanghuicheng chineseexpertconsensusoniodine125seedimplantationforrecurrentcervicalcancerin2021 AT baoshengsun chineseexpertconsensusoniodine125seedimplantationforrecurrentcervicalcancerin2021 AT fuquanzhang chineseexpertconsensusoniodine125seedimplantationforrecurrentcervicalcancerin2021 AT ruoyuwang chineseexpertconsensusoniodine125seedimplantationforrecurrentcervicalcancerin2021 AT tiejunwang chineseexpertconsensusoniodine125seedimplantationforrecurrentcervicalcancerin2021 AT angqu chineseexpertconsensusoniodine125seedimplantationforrecurrentcervicalcancerin2021 AT xiangkunyuan chineseexpertconsensusoniodine125seedimplantationforrecurrentcervicalcancerin2021 AT binqiu chineseexpertconsensusoniodine125seedimplantationforrecurrentcervicalcancerin2021 AT shuhuawei chineseexpertconsensusoniodine125seedimplantationforrecurrentcervicalcancerin2021 AT ziliu chineseexpertconsensusoniodine125seedimplantationforrecurrentcervicalcancerin2021 AT yunyanzhang chineseexpertconsensusoniodine125seedimplantationforrecurrentcervicalcancerin2021 AT junjiewang chineseexpertconsensusoniodine125seedimplantationforrecurrentcervicalcancerin2021
_version_	1718441290147823616

Chinese Expert Consensus on Iodine125 Seed Implantation for Recurrent Cervical Cancer in 2021

Ejemplares similares